Literature DB >> 28329491

Congenital erythropoietic porphyria (Gunther disease) - long-term follow up of a case and review.

Matthew Howard1, Anthony Hall, Donald Ramsay.   

Abstract

Patients with the rare genodermatosis congenitalerythropoietic porphyria (CEP, Gunther disease)develop erosions and scarring on sun-exposedsites caused by phototoxin mediated damage.Compromised skin barrier function places patientsat higher risk of infection and long term sequelaeinclude scarring. We report a long term follow up ofa 60 year old patient born with CEP and provide anextensive literature review of CEP including recentupdates on potential management options. Multiplepatient interviews and collection of biochemistry datawere conducted for the case discussion. All Australianpathology laboratories in each state performingporphyria testing were surveyed in mid 2015 to verifyexistence of other cases of CEP in Australia with onlyone case of true congenital porphyria identifiedand one adult onset case. Congenital erythropoieticporphyria is a rare condition with no cure currentlyavailable. It is important to diagnose patients earlyto prevent and minimize complications such asscarring and secondary infection, provide longterm skin checks, and advise patients about lifestylemodification.

Entities:  

Mesh:

Year:  2017        PMID: 28329491

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  4 in total

Review 1.  Congenital erythropoietic porphyria: Recent advances.

Authors:  Angelika L Erwin; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2018-12-27       Impact factor: 4.797

2.  Congenital erythropoietic porphyria (Gunther disease): a case report.

Authors:  Ali Kahila; Ali Zamlout; Abdaljawad Mazloum; Omar Laila; Ayham Badran
Journal:  Oxf Med Case Reports       Date:  2020-07-24

3.  Scleritis in congenital erythropoietic porphyria - infective or inflammatory?

Authors:  Pranita Sahay; Suman Dhanda; Deepali Singhal; Prafulla K Maharana; Jeewan S Titiyal; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

4.  Commentary: Discerning the porhyrias!

Authors:  S Bala Murugan
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.